These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8156232)

  • 1. Febrile neutropenia.
    Klastersky J
    Support Care Cancer; 1993 Sep; 1(5):233-9. PubMed ID: 8156232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.
    Menichetti F; Martino P; Bucaneve G; Gentile G; D'Antonio D; Liso V; Ricci P; Nosari AM; Buelli M; Carotenuto M
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2041-6. PubMed ID: 7811016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime plus amikacin versus ceftazidime plus vancomycin as empiric therapy in febrile neutropenic children with cancer.
    Viscoli C; Moroni C; Boni L; Bruzzi P; Comelli A; Dini G; Fabbri A; Secondo V; Terragna A
    Rev Infect Dis; 1991; 13(3):397-404. PubMed ID: 1866542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic therapy protocol using ceftazidime 3g/day alone or in combination with vancomycin or amikacin. In febrile episodes in neutropenic patients].
    Marie JP; Pico JL; Chiche D; Fitoussi F; Delmer A; Baume D; Rio B; Ajchenbaum F; Richet H; Tancrède C
    Presse Med; 1988 Oct; 17(37):1968-70. PubMed ID: 2973598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meropenem monotherapy versus combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients.
    Behre G; Link H; Maschmeyer G; Meyer P; Paaz U; Wilhelm M; Hiddemann W
    Ann Hematol; 1998 Feb; 76(2):73-80. PubMed ID: 9540761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of fever in neutropenic patients.
    Bodey GP; Rolston KV
    J Infect Chemother; 2001 Mar; 7(1):1-9. PubMed ID: 11406750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftazidime plus amikacin plus teicoplanin or vancomycin in the empirical antibiotic therapy in febrile neutropenic cancer patients.
    Nucci M; Biasoli I; Braggio S; Portugal R; Schaffel R; Maiolino A; Loureiro MM; Spector N; Pulcheri W
    Oncol Rep; 1998; 5(5):1205-9. PubMed ID: 9683836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia.
    Santhosh-Kumar CR; Ajarim DS; Harakati MS; al Momen AK; al Mohareb F; Zeitany RG
    J Infect; 1992 Jul; 25(1):11-9. PubMed ID: 1365011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer.
    Riikonen P
    Pediatr Infect Dis J; 1991 Dec; 10(12):918-23. PubMed ID: 1766707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric antifungal therapy in febrile granulocytopenic patients. EORTC International Antimicrobial Therapy Cooperative Group.
    Am J Med; 1989 Jun; 86(6 Pt 1):668-72. PubMed ID: 2658574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Croydon E; Weerts D
    Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585
    [No Abstract]   [Full Text] [Related]  

  • 12. Ceftazidime with or without vancomycin vs. cephalothin, carbenicillin and gentamicin as the initial therapy of the febrile neutropenic pediatric cancer patient.
    Granowetter L; Wells H; Lange BJ
    Pediatr Infect Dis J; 1988 Mar; 7(3):165-70. PubMed ID: 3282214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prospective and comparative study of 2 antibiotic therapy protocols in 66 febrile neutropenic patients. Ceftazidime-vancomycin versus ticarcillin-vancomycin-amikacin].
    Brion JP; Bru JP; Michallet M; Corron B; Fauconnier J
    Presse Med; 1988 Oct; 17(37):1964-7. PubMed ID: 2973597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients.
    Anaissie EJ; Fainstein V; Bodey GP; Rolston K; Elting L; Kantarjian H; Cabanillas F; McCredie KB
    Am J Med; 1988 Mar; 84(3 Pt 2):581-9. PubMed ID: 3279774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.
    J Infect Dis; 1991 May; 163(5):951-8. PubMed ID: 2019772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empiric therapy for infections in the febrile, neutropenic, compromised host.
    Giamarellou H
    Med Clin North Am; 1995 May; 79(3):559-80. PubMed ID: 7752729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
    Leverger G; Demeocq F; Harousseau JL; Taboureau O; Vannier JP; Boilletot A; de Lumley L; Boutard P; Olive D; Reinert P
    Pathol Biol (Paris); 1987 May; 35(5):648-51. PubMed ID: 3302878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study.
    Krupova Y; Novotny J; Sabo A; Mateicka F; Krcmery V
    Int J Antimicrob Agents; 1998 Nov; 10(4):313-6. PubMed ID: 9916907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients.
    Glauser MP; Brennscheidt U; Cornely O; Grigg A; Figuera A; Keyserling C; Trostmann U; Welling L; Tack K
    Clin Microbiol Infect; 2002 Jan; 8(1):14-25. PubMed ID: 11906496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.